Ontology highlight
ABSTRACT:
SUBMITTER: Davis TA
PROVIDER: S-EPMC3880828 | biostudies-literature | 2013 Nov
REPOSITORIES: biostudies-literature
The Journal of organic chemistry 20131015 21
Chiral nonracemic cis-4,5-bis(aryl)imidazolines have emerged as a powerful platform for the development of cancer chemotherapeutics, stimulated by the Hoffmann-La Roche discovery that Nutlin-3 can restore apoptosis in cells with wild-type p53. The lack of efficient methods for the enantioselective synthesis of cis-imidazolines, however, has limited their more general use. Our disclosure of the first enantioselective synthesis of (-)-Nutlin-3 provided a basis to prepare larger amounts of this too ...[more]